ArticleJACC. Case reports2026
Transcatheter Electrosurgical Loop Resection of a Right Ventricular Fibromyxoma.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSurgical excision remains the standard of care for primary cardiac tumors. However, advances in catheter-based electrosurgical techniques have enabled minimally invasive resection of selected intracardiac masses. CASE SUMMARY: A 19-year-old male patient was identified with a neoplasm in the right ventricle after a medical evaluation. The possibility of performing a transfemoral excision of the tumor was taken into consideration, as the patient wanted to pursue a professional football career. Coagulation was used to remove the mass, and snare systems were used to entirely retrieve it. The procedure was technically successful without any complications. DISCUSSION: This method validates the technical viability of whole mass removal via venous access and broadens the use of transcatheter structural treatment of intracardiac masses. TAKE-HOME MESSAGES: Transcatheter removal of a right ventricular fibromyxoma may be a safe alternative to open surgery in certain patients. A successful outcome requires careful planning, precise visualization, and coordinated multidisciplinary teamwork.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.